Fitzgerald Charles Buys 220,000 Shares of Chiron’s 6% Series C Preferred Stock – Insider Buy Spurs Confidence
Fitzgerald Charles’s $100 premium buy of 220,000 shares in Chiron’s 6% Series C convertible preferred stock signals strong insider confidence in the medical‑REIT’s growth, offering income and upside potential.
4 minutes to read





